|
|
| | Benzamide, 4-[2-[4-(dimethylamino)phenyl]diazenyl]-N-[2-hydroxy-5-(2-thienyl)phenyl]- Basic information |
| | Benzamide, 4-[2-[4-(dimethylamino)phenyl]diazenyl]-N-[2-hydroxy-5-(2-thienyl)phenyl]- Chemical Properties |
| Boiling point | 586.1±50.0 °C(Predicted) | | density | 1.25±0.1 g/cm3(Predicted) | | pka | 8.61±0.48(Predicted) |
| | Benzamide, 4-[2-[4-(dimethylamino)phenyl]diazenyl]-N-[2-hydroxy-5-(2-thienyl)phenyl]- Usage And Synthesis |
| Description | BG47 is a novel probe for chemo-optical modulation of epigenetically regulated transcription (COMET). It enables high-resolution, optical control of epigenetic mechanisms and photochromically inhibits human histone deacetylases using visible light. | | Uses | BG47 is a prototypical histone deacetylases HDAC1 and HDAC2 selective, optoepigenetic probe. BG47 can bind to and competitively inhibits the deacetylase activity of HDAC targets upon a light-induced trans-to-cis isomerization, and increases Histone Methyltransferase H3K9 acetylation. BG47 can be used for neurological disease research[1]. | | IC 50 | HDAC1; HDAC2 | | References | [1] Reis SA, et al. Light-controlled modulation of gene expression by chemical optoepigenetic probes. Nat Chem Biol. 2016 May;12(5):317-23. DOI:10.1038/nchembio.2042 |
| | Benzamide, 4-[2-[4-(dimethylamino)phenyl]diazenyl]-N-[2-hydroxy-5-(2-thienyl)phenyl]- Preparation Products And Raw materials |
|